Pranlukast

CHEMBL21333 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

481.5 g/mol

LogP

4.2

Phase

4

Pranlukast is a cysteinyl leukotriene receptor-1 (CysLT1) antagonist that blocks the bronchoconstrictor and pro-inflammatory actions of leukotrienes C4, D4, and E4 in the airways, reducing asthma symptoms including bronchospasm, mucus secretion, and airway eosinophilia. It is used in Japan and other Asian countries for the maintenance treatment of asthma and allergic rhinitis.

Berat Molekul

481,5000 g/mol

LogP

4,20

TPSA

119,00 Å²

Lipinski RO5

Lulus

Area Terapeutik

Asthma

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(Nc1cccc2c(=O)cc(-c3nnn[nH]3)oc12)c1ccc(OCCCCc2ccccc2)cc1

InChI

InChI=1S/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32)

Molecular Formula

C27H23N5O4

HBD / HBA

2 / 7

Ikatan yang Dapat Dirotasi

9

Atom Berat

36

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Pranlukast is a cysteinyl leukotriene receptor-1 (CysLT1) antagonist that blocks the bronchoconstrictor and pro-inflammatory actions of leukotrienes C4, D4, and E4 in the airways, reducing asthma symptoms including bronchospasm, mucus secretion, and airway eosinophilia. It is used in Japan and other Asian countries for the maintenance treatment of asthma and allergic rhinitis.

Yes, Pranlukast is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL21333. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4887. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Pranlukast di PillFYI

Struktur

Data Cepat

Rumus: C27H23N5O4

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.